Dialysis Facility Ownership and Epoetin Dosing in Hemodialysis Patients: A Dialysis Provider’s Perspective
No abstract is available. To read the body of this article, please view the Full Text online.
Fresenius Medical Care North America
Address correspondence to J. Michael Lazarus, MD, or Raymond M. Hakim, MD, PhD, Fresenius Medical Care North America, 920 Winter St, Lexington, MA 02451.
